Anupama Deepa Kumar, MD¹, Suheil Albert Atallah-Yunes, MD², Sridevi Rajeeve, MD³, Ahmed Abdelhak^1*, Hamza Sloan Hashmi, MD^4*, Andre Corraes, MD^2*, Myo Htut, MD⁵, Paula Rodriguez-Otero^6*, Ricardo D. Parrondo, MD⁷, Saurabh Chhabra, MD⁸, K. Martin Kortüm, MD^9*, Lukas Scheller, MD^10*, Sofie-Katrin Kadel, MD^11*, Hermann Einsele, MD¹², Niels W.C.J. van de Donk¹³, Jana Mihalyova^14*, Roman Hajek, MD, PhD¹⁵, Joaquin Martinez Lopez, PhD, MD^16*, Noa Biran, MD¹⁷, Carlos Fernández de Larrea, MD¹⁸, Ingerid Weum Abrahamsen, MD, PhD^19*, Szu-Ying Chen, PhD^20*, Melissa Ng^21*, Bonell Patino Escobar^22*, Simon J Harrison, MBBS, PhD²³, Caitlin Costello, MD²⁴, Isadora Matos^25*, Edvan Crusoe^26*, Luciano J. Costa, MD, PhD²⁷, Arun P Wiita, MD, PhD²⁸, Sasha Gupta, MD^29*, Thomas Martin, MD³⁰, Yi Lin, MD, PhD² and Ajai Chari, MD¹

¹University of California, San Francisco, San Francisco, CA
²Division of Hematology, Mayo Clinic, Rochester, MN
³Myeloma & Cellular Therapy Services, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
⁶University of Navarra, Madrid, ESP
⁷Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁸Division of Hematology, Mayo Clinic, Phoenix, AZ
⁹Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
¹⁰Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
¹¹University Hospital of Würzburg, Hannover, DEU
¹²University Hospital of Würzburg;, Wurzburg, Germany
¹³Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹⁴Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
¹⁵University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic
¹⁶Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁷Division of Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
¹⁸Hospital Clínic de Barcelona, Barcelona, Spain
¹⁹Oslo University Hospital, Oslo, Norway
²⁰Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
²¹University of Melbourne, Melbourne, Australia
²²Universit of California, San Francisco, San Francisco
²³Peter MacCallum Cancer Centre, Melbourne, Australia
²⁴Moores Cancer Center, University of California, San Diego, San Diego, CA
²⁵Universidade Federal Da Bahia, Salvador, Brazil
²⁶Hospital Universitário Professor Edgar Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil
²⁷Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
²⁸Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
²⁹Department of Neurology, University of California, San Francisco, San Francisco, CA
³⁰Department of Medicine, University of California, San Francisco, CA

Markus Maulhardt^1*, Philipp Berning^2*, Christine Hanoun^3*, Hristo Boyadzhiev^4,5*, Anca Maria Albici^6*, Snjezana Janjetovic^7*, Anna Ossami Saidy^7*, Simon Call^2*, Natalie Schub^6*, Enver Aydilek^1*, Michael Daskalakis^8*, Wolfram Jung^1*, Justin Hasenkamp^1*, Carolin Krekeler^2*, Cyrus Khandanpour⁹, Ulrike Bacher^8*, Hans Christian Reinhardt³, Georg Lenz², Friedrich Stölzel^6*, Gerald Wulf^1*, Thomas Pabst⁴, Bastian von Tresckow³ and Evgenii Shumilov^2*

¹Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
²Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
³Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁴Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
⁵Habichtswald Hospital, Kassel, Germany
⁶Division of Stem Cell Transplantation and Cellular Immunotherapies, University Hospital Schleswig-Holstein, Kiel, Germany
⁷Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
⁸Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
⁹Department of Hematology and Oncology, University Hospital Schleswig-Holstein, University of Luebeck, Luebeck, Germany

Benoit Ferment^1*, Amani Ouedrani, MD^2*, Romain Stammler, MD^3*, William Dartois^2*, Stephanie Harel, MD^4*, Bruno Royer, MD^4*, Nathalie Forgeard, MD^4*, Tristan Vaugeois, MD^4*, Alexis Talbot, MD^1,4*, Jean-Christophe Bories^1*, Bertrand Arnulf, MD^1,4 and Sophie Caillat-Zucman, MD^1,2*

¹Inserm U976 HIPI, Hôpital Saint Louis, Paris, France
²Immunology Laboratory, Hôpital Saint-Louis, AP-HP, Paris, France
³Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France
⁴Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France

Chunrui Li, MD, PhD¹, Dehui Zou^2*, Di Wang^1*, Baijun Fang^3*, He Huang^4*, Jianyong Li, MD⁵, Bing Chen⁶, Jing Liu, PhD^7*, Xi Zhang, PhD⁸, Yujun Dong^9*, Kai Hu, MD¹⁰, Peng Liu, MD¹¹, Jianqing Mi¹², Kaiyang Ding^13*, Zhenyu Li^14*, Qie Dong^15*, Fuyuan Zhang^15*, Guang Hu, PhD¹⁵ and Lu-Gui Qiu²

¹Institute of Hematology；Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
⁴The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⁶Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
⁷Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
⁸Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China
⁹Department of Hematology, Peking University First Hospital, Beijing, China
¹⁰Beijing GoBroad Boren Hospital, Beijing, China
¹¹Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
¹²State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
¹³Department of Hematology, The First Affiliated Hospital of USTC, Hefei, CHN
¹⁴The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹⁵Nanjing IASO Biotechnology Co., Ltd., Nanjing, China

Wenming Chen^1*, Chengcheng Fu^2*, Baijun Fang^3*, Aibin Liang^4*, Zhongjun Xia, MD^5*, Yanjuan He^6*, Jin Lu^7*, Hui Liu^8*, Ming Hou^9*, Zhen Cai^10*, Wei Yang^11*, Siguo Hao^12*, Songfu Jiang^13*, Hongmei Jing, MD¹⁴, Jing Liu, PhD^15*, Xin Du^16*, Rong Fu^17*, Heng Mei^18*, Zunmin Zhu^19*, Yanli Yang^20*, Hong Liu^21*, Xingxing Meng^22*, Nishanthan Rajakumaraswamy^22*, Wei Zheng^22*, Huamao Wang^22* and Zonghai Li^22*

¹Beijing chaoyang Hospital affiliated to Capital Medical University, Beijing, China
²The First Affiliated Hospital of Soochow University, Suzhou, China
³Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Henan, China
⁴Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
⁵Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁶Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
⁷National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Beijing, China
⁸Department of Hematology, Beijing Hospital, Beijing, China
⁹Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
¹⁰Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
¹¹Department of Hematology, Shengjing Hospital affiliated to China Medical University, Shenyang, China
¹²Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
¹³Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
¹⁴Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China
¹⁵Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
¹⁶Department of Hematology, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
¹⁷Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
¹⁸Department of Haematology, Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China
¹⁹Department of Hematology, Henan Provincial People's Hospital, Zhengzhou, China
²⁰The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
²¹Affiliated Hospital of Nantong University, Nantong, China
²²CARsgen Therapeutics Co. Ltd., Shanghai, China

QI Deng^1*, Xin Li^2*, Qing Li^3*, Jia Wang^4*, Juan Mu^5* and Rui Cui^6*

¹Tianjin First Central Hospital, Tianjin, China
²Tianjin First Centre Hospital, Tianjin, AL, China
³Tianjin first central hospital of China, Tianjin, China
⁴Department of Hematology, Tianjin First Central Hospital, Tianjin, CA, China
⁵Department of Hematology, Tianjin First Central Hospital, Tianjin, China
⁶Tianjin First center hospital, Tianjin, CA, China

Xinzhuo Chen^1,2*, Renhua Huang^1,2*, Huiping Wang^2,3*, Hao Xiao^2,4*, Qian Li, MD^1,2*, Zhimin Zhai, MD^2,5 and Zhitao Wang, PhD^1,2*

¹Department of Hematology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China
²Center of Hematology Research, Anhui Medical University, Hefei, China
³Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China
⁴Hematologic Department/Hematologic Diseases Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, China
⁵Department of hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

Bertrand Arnulf, MD¹, Laetitia Vercellino, MD, PhD^2*, Denis Caillot, MD^3*, Jérôme Lambert, MD, PhD^4,5*, Bastien Jamet, MD^6*, Aurore Perrot, MD, PhD^7,8,9, Pierre Bories, MD, PhD^10*, Olivier Decaux, MD, PhD^11*, Lionel Karlin, MD^12*, Anne Lazareth^12*, Laure Vincent, MD^13*, Christine Latry Kuhn^14*, Cyrille Touzeau, MD, PhD^15,16,17*, Harel Stephanie, MD^18,19*, Mohamad Mohty, MD, PhD^20,21,22, Florent Malard, M.D., Ph.D.^23*, Salomon Manier, MD, PhD^24,25, Ibrahim Yakoub-Agha, MD, PhD^26*, Alexis Talbot^27*, Niels Moya, MD, PhD^28,29,30, Arthur Bobin^31,32*, Marie-Odile Petillon, MD^33*, Noemie Bigot^34*, Thierry Facon, MD^35,36, Jill Corre, PharmD, PhD^37*, Herve Avet-Loiseau, MD, PhD^38*, Philippe Moreau, MD, PhD^39,40* and Françoise Kraeber-Bodéré, MD, PhD^41*

¹Hôpital Saint-Louis, APHP, Université Paris cite, Paris, France
²Nuclear Medicine Department, Hopital Saint Louis, Paris, France
³Institut de cancérologie de Bourgogne clinique Drevon, dijon, France
⁴Biostatistics and Medical Information Department, Saint Louis University Hospital, AP-HP, Paris, France
⁵ECSTRRA team, Centre for Research in Epidemiology and Statistics, INSERM U1153, Université Paris Cité, Paris, France
⁶Service de Médecine Nucléaire - CRCI2NA, CHU Nantes, Nantes, France
⁷Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
⁸Hematology, University Cancer Institute of Toulouse Oncopole, Toulouse, France
⁹Hématologie, Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France
¹⁰hematologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
¹¹Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes, France
¹²Hématologie Clinique, Centre Hospitalier Lyon Sud, Lyon, France
¹³Department of Clinical Hematology, Hôpital St Eloi, CHU de Montpellier, Montpellier, France
¹⁴Hématologie Clinique, CHU Montpellier, Montpellier, France
¹⁵Centre Hospitalier Universitaire de Nantes, Nantes, France
¹⁶Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
¹⁷CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
¹⁸Department of Immuno-hematology,, Saint Louis Hospital, APHP, Paris, France
¹⁹Department of Immuno-hematology,, University Hospital of Saint Louis, Paris, France
²⁰Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
²¹Hôpital Saint Antoine, Paris, FRA
²²Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France
²³Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Service d'Hématologie Clinique et Thérapie Cellulaire,Centre de Recherche Saint-Antoine UMRs938, Paris, France
²⁴Centre Hospitalier Universitaire - Hôpital Huriez, Lille, France
²⁵Department of Hematology, Lille University Hospital, Lille, France
²⁶CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, LILLE, France
²⁷Immuno-hematology department, Hôpital Saint Louis, Université Paris Cité, Paris, France
²⁸Centre Hospitalier Universitaire - La Milétrie, Poitiers, France
²⁹Department of Oncology-Haematology and Cell Therapy, CHU, Poitiers, INSERM, Inserm CIC 1402, Poitiers, France, Poitiers, France
³⁰Poitiers University Hospital, Poitiers, France
³¹CHU Poitiers, Poitiers, France
³²Hematology department & CIC 1402, Poitiers University Hospital, Poitiers, France
³³Intergroupe Francophone du Myelome, Paris, France
³⁴Biostatistics Department, Hôpital Saint Louis, APHP, Paris, France
³⁵University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
³⁶Department of Haematology, Lille University Hospital, Lille, France
³⁷Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
³⁸Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France
³⁹Hematology, University Hospital of Nantes, Nantes, France
⁴⁰University Hospital Hôtel-Dieu, Nantes, France
⁴¹CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France

Xiaolan Shi^1*, Chengcheng Fu^1*, Lingzhi Yan^1*, Yingying Zhai^1*, Zhi Yan^1*, Jingjing Shang^1*, Song Jin^1*, Xingyue Wu^1*, Hongying You^1*, Shuang Yan^1*, Weiqin Yao^1*, Liqing Kang^2*, Lei Yu^2* and Depei Wu, MD, PhD¹

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China